9月21日消息,摩根士丹利(MS)(MS.US)发表研报指,《医药工业发展“十五五”规划》提到,目标中国创新药(886015)行业在2030年复合年增长逾20%,相当于行业规模扩大至现时约2.5倍。规划亦明确支持中国生物医药企业与全球伙伴共同开发及商业化,并加强知识产权保护(885791)及监管标准协调,有助缓解地缘政治顾虑。大摩又提到,规划优先发展AI赋能的靶点发现及分子设计/优化等应用。器械及...
Source Link9月21日消息,摩根士丹利(MS)(MS.US)发表研报指,《医药工业发展“十五五”规划》提到,目标中国创新药(886015)行业在2030年复合年增长逾20%,相当于行业规模扩大至现时约2.5倍。规划亦明确支持中国生物医药企业与全球伙伴共同开发及商业化,并加强知识产权保护(885791)及监管标准协调,有助缓解地缘政治顾虑。大摩又提到,规划优先发展AI赋能的靶点发现及分子设计/优化等应用。器械及...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.